In various studies and clinical reports, the hypersecretion of insulin has been linked to the development of several types of cancer, including breast, colon, liver, and kidney cancers [66,67], and the survival rates through GEPIA in our research also confirmed that higher the expression levels of the two genes, the better is the survival rate (Figure S4A). The gene discussed is INS; the disease is cancer.